PVLA
Palvella Therapeutics, Inc
132.50$
-0.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | |
| – | – | – | – | – | – | – | 7.5% | 10.7% | – | – | – | |
| – | – | – | – | – | – | 100.0% | 92.5% | 89.3% | – | – | – | |
| 104.4% | 260.7% | 337.8% | 86.7% | 140.6% | 117.5% | 150.8% | 204.3% | 193.9% | – | – | – | |
| – | – | – | – | – | – | – | – | 16.0% | – | – | – | |
| 227.3% | 535.6% | 484.1% | 156.3% | 204.0% | 156.4% | 208.4% | 257.4% | 257.1% | – | – | – | |
| -134.2% | -446.1% | -390.3% | -57.7% | -105.9% | -58.7% | -115.7% | -165.0% | -167.8% | – | – | – | |
| 49.5% | – | – | – | – | – | – | – | – | – | – | – | |
| -183.6% | -472.5% | -388.2% | -65.5% | -93.0% | -55.0% | -126.4% | -145.6% | -128.5% | – | – | – | |
| 0.0% | 7.0% | 2.8% | 4.4% | -1.1% | – | 0.6% | – | -4.0% | – | – | – | |
| -183.6% | -479.5% | -391.0% | -69.8% | -91.9% | -55.0% | -127.0% | -145.6% | -128.5% | – | – | – | |
| -127.3% | -462.0% | -382.0% | -64.0% | -91.0% | -52.8% | -119.2% | -138.0% | -117.7% | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.